Breast cancer study aims to see what treatments patients actually get
NCT ID NCT07151911
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This observational study follows 100 people with high-risk, hormone receptor-positive, HER2-negative early breast cancer who are already taking a combination of abemaciclib, olaparib, and endocrine therapy. Researchers will track which treatments doctors choose and how patients' quality of life changes over 5 years. The goal is to better understand real-world treatment patterns and patient experiences.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- abemaciclib, olaparib, and endocrine therapy
- What this could lead to
- If successful, this study could help doctors better understand which treatments work best for high-risk early breast cancer patients and improve quality of life monitoring.
- What could go wrong
- This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all patients, and the small size (100 participants) limits generalizability.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero Universitaria Policlinico di Modena
RECRUITINGModena, Modena, 41124, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a radioactive tracer pinpoint Cancer's first stop?
- Can a personalized exercise program boost recovery in cancer survivors?
- Smartwatch could spot nerve damage before it starts
- Could ionized gas help fight breast cancer after surgery?
- Radiation may let breast cancer patients keep their nipple
- Can a smart digital program restore sleep for cancer survivors?